THE IMPACT OF SEVERE FIBROSIS AND ANTIVIRAL THERAPY ON THE COURSE OF RECURRENT HEPATITIS C AFTER LIVER TRANPLANTATION

被引：0
|
作者：
Donato, Maria F. [1 ]
Rigamonti, Cristina [1 ]
Agnelli, Francesca [1 ]
Arosio, Eliana [1 ]
Rossi, Giorgio [2 ]
Colombo, Massimo [1 ]
机构：
[1] IRCCS Fdn Osped Maggiore Policlin, Div Gastroenterol 1, Milan, Italy
[2] IRCCS Fdn Osped Maggiore Policlin, Liver Transplant Unit, Milan, Italy
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
527
引用
收藏
页码：556A / 557A
页数：2
相关论文
共 50 条
  • [21] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    Neumann, UP
    Berg, T
    Harren, M
    Langrehr, JM
    Neuhaus, P
    LIVER TRANSPLANTATION, 2003, 9 (06) : C33 - C33
  • [22] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    Feray, C
    JOURNAL OF HEPATOLOGY, 2004, 41 (05) : 862 - 863
  • [23] Effect of timing of interferon therapy on fibrosis progression in recurrent hepatitis C infection after liver transplantion
    Ghabril, MS
    Krishna, M
    Machicao, VI
    Bonatti, H
    Borlaza, RF
    Rosser, B
    Satyanarayana, R
    Aranda-Michel, J
    Aqel, B
    Keaveny, A
    Harnois, D
    Hewitt, W
    Grewal, H
    Nguyen, J
    Hughes, C
    Steers, J
    Dickson, RC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 498 - 498
  • [24] ANTIVIRAL THERAPY OF HEPATITIS C WITH 1 GENOTYPE AFTER LIVER TRANSPLANTATION
    Tsiroulnikova, O. M.
    Umrik, D. V.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2018, 20 (03): : 105 - 115
  • [25] Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review
    De Martin, E.
    Senzolo, M.
    Gambato, M.
    Germani, G.
    Vitale, A.
    Russo, F. R.
    Burra, P.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (06) : 2223 - 2225
  • [26] Changes in liver fibrosis in patients with chronic hepatitis C after successful direct-acting antiviral therapy
    Sadeghi, Anahita
    Amiri, Roya
    Akbarpour, Elham
    Mirminachi, Babak
    Sharifi, Amir-Houshang
    Merat, Shahin
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [27] Can histological factors predict evolution towards severe fibrosis in recurrent hepatitis C after liver transplantation?
    Bralet, M
    Roudot-Thoraval, F
    Zrara, I
    Duvoux, C
    Cherqui, D
    Dhumeaux, D
    Mavier, P
    Zafrani, E
    JOURNAL OF HEPATOLOGY, 2001, 34 : 175 - 175
  • [28] Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center
    Walter, Thomas
    Dumortier, Jerome
    Guillaud, Olivier
    Hervieu, Valerie
    Scoazec, Jean-Yves
    Boillot, Olivier
    LIVER TRANSPLANTATION, 2007, 13 (02) : 294 - 301
  • [29] Predictive Factors of Lack of Response to Antiviral Therapy Among in Patients With Recurrent Hepatitis C After Liver Transplantation
    Marino, M.
    Iemmolo, R. M.
    Montalti, R.
    Bertolotti, M.
    Di Benedetto, F.
    De Ruvo, N.
    Cautero, N.
    Guerrini, G.
    De Blasiis, M. G.
    Gerunda, G. E.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1223 - 1225
  • [30] Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation
    Ueda, Yoshihide
    Kaido, Toshimi
    Ito, Takashi
    Ogawa, Kohei
    Yoshizawa, Atsushi
    Fujimoto, Yasuhiro
    Mori, Akira
    Miyagawa-Hayashino, Aya
    Haga, Hironori
    Marusawa, Hiroyuki
    Chiba, Tsutomu
    Uemoto, Shinji
    TRANSPLANTATION, 2014, 97 (03) : 344 - 350
12345